Beleid vroegdiagnostiek prostaatcarcinoom aangepast. NHG-standaard adviseert vaker verwijzen, minder invasief onderzoek

Marco H. Blanker; Theo M. de Reijke; R. J. A. Jeroen van Moorselaar; Wim Opstelten

Beleid vroegdiagnostiek prostaatcarcinoom aangepast. NHG-standaard adviseert vaker verwijzen, minder invasief onderzoek

Marco H. Blanker, Theo M. de Reijke, R. J. A. Jeroen van Moorselaar, Wim Opstelten

Research output: Contribution to journal › Article › Professional

5 Citations (Scopus)

Abstract

Major disadvantages are associated with the early diagnostics of prostate cancer; for this reason routine determination of PSA level is not recommended in the Netherlands. If, after guidance, the patient still wants further investigations and rectal examination is not abnormal, the Dutch College of General Practitioners guideline 'Micturition problems in men' recommends that a PSA test should be done. The cut-off PSA level for referring patients for secondary care has been lowered from 4 ng/ml to 3 ng/ml, meaning that this guideline is now in accordance with the Dutch Society for Urology's multidisciplinary guideline "Prostate Carcinoma". Using the Prostate Cancer Risk Calculator (Prostaatwijzer-3), the PSA level and ultrasound-guided measurement of prostate volume can be used to calculate the risk of prostate cancer. The risk calculated is then used a starting point in determining if invasive follow-up diagnostic tests should be implemented

Original language	Dutch
Pages (from-to)	A8070
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	158
Publication status	Published - 2014

Cite this

@article{dd8c4fedc6e14f2c94af78b56a08aed3,

title = "Beleid vroegdiagnostiek prostaatcarcinoom aangepast. NHG-standaard adviseert vaker verwijzen, minder invasief onderzoek",

abstract = "Major disadvantages are associated with the early diagnostics of prostate cancer; for this reason routine determination of PSA level is not recommended in the Netherlands. If, after guidance, the patient still wants further investigations and rectal examination is not abnormal, the Dutch College of General Practitioners guideline 'Micturition problems in men' recommends that a PSA test should be done. The cut-off PSA level for referring patients for secondary care has been lowered from 4 ng/ml to 3 ng/ml, meaning that this guideline is now in accordance with the Dutch Society for Urology's multidisciplinary guideline {"}Prostate Carcinoma{"}. Using the Prostate Cancer Risk Calculator (Prostaatwijzer-3), the PSA level and ultrasound-guided measurement of prostate volume can be used to calculate the risk of prostate cancer. The risk calculated is then used a starting point in determining if invasive follow-up diagnostic tests should be implemented",

author = "Blanker, {Marco H.} and {de Reijke}, {Theo M.} and {van Moorselaar}, {R. J. A. Jeroen} and Wim Opstelten",

year = "2014",

language = "Dutch",

volume = "158",

pages = "A8070",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Vereniging Nederlands Tijdschrift voor Geneeskunde",

}

TY - JOUR

T1 - Beleid vroegdiagnostiek prostaatcarcinoom aangepast. NHG-standaard adviseert vaker verwijzen, minder invasief onderzoek

AU - Blanker, Marco H.

AU - de Reijke, Theo M.

AU - van Moorselaar, R. J. A. Jeroen

AU - Opstelten, Wim

PY - 2014

Y1 - 2014

N2 - Major disadvantages are associated with the early diagnostics of prostate cancer; for this reason routine determination of PSA level is not recommended in the Netherlands. If, after guidance, the patient still wants further investigations and rectal examination is not abnormal, the Dutch College of General Practitioners guideline 'Micturition problems in men' recommends that a PSA test should be done. The cut-off PSA level for referring patients for secondary care has been lowered from 4 ng/ml to 3 ng/ml, meaning that this guideline is now in accordance with the Dutch Society for Urology's multidisciplinary guideline "Prostate Carcinoma". Using the Prostate Cancer Risk Calculator (Prostaatwijzer-3), the PSA level and ultrasound-guided measurement of prostate volume can be used to calculate the risk of prostate cancer. The risk calculated is then used a starting point in determining if invasive follow-up diagnostic tests should be implemented

AB - Major disadvantages are associated with the early diagnostics of prostate cancer; for this reason routine determination of PSA level is not recommended in the Netherlands. If, after guidance, the patient still wants further investigations and rectal examination is not abnormal, the Dutch College of General Practitioners guideline 'Micturition problems in men' recommends that a PSA test should be done. The cut-off PSA level for referring patients for secondary care has been lowered from 4 ng/ml to 3 ng/ml, meaning that this guideline is now in accordance with the Dutch Society for Urology's multidisciplinary guideline "Prostate Carcinoma". Using the Prostate Cancer Risk Calculator (Prostaatwijzer-3), the PSA level and ultrasound-guided measurement of prostate volume can be used to calculate the risk of prostate cancer. The risk calculated is then used a starting point in determining if invasive follow-up diagnostic tests should be implemented

M3 - Article

C2 - 25492733

SN - 0028-2162

VL - 158

SP - A8070

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

ER -